Our Pipeline
Rapidly advancing a deep portfolio of innovative autoimmune therapeutics that continues to expand through our successful business development strategy.
Latest News
September 5, 2023
Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb
August 1, 2023